Clinical Trials, DEA, History, Programs and Events

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Trials

DEA

History

Programs

Events

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

MARCH 2, 2020

This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. This landmark approval is unique in that ketamine is well known to have hallucinogenic properties, as well as a long history as a party drug. Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA).

Medicine

Medicine Therapy DEA Pharmaceutical

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

Clinical Trials

Clinical Trials Therapy Research and Development DEA

Medical Cannabis Brief

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Stay Connected